Skip to main content
AGL logo

AGL · agilon health, inc. · Analyst Estimates

Track AGL — free
$82.28 +2.69 (+3.38%)
Market Cap
$1.37B
Shares
16.79M
Volume · Oct 1 262.32K Avg daily vol (3M) 294.84K

Analyst Estimates

Compare analyst forecasts for agilon health, inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-26 11:11 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-5.34
-1.78506
2.07
—
-1.60168
-2.87629
-1.64585
-2.93013
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
1
0
9
1
Revenue
USD
Publication date not stated
5780000000
5827314220
5893487000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.38
2.40143
6.15
—
1.76475
-0.6215
3.19833
-0.61688
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
6
1
Revenue
USD
Publication date not stated
5990800000
6244908490
6607400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.36
-0.64
-0.25
—
-0.754
-0.66914
-0.754
-0.64917
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
4
1
2
1
Revenue
USD
Publication date not stated
1450646000
1461040170
1483871000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-6.37
-3.70896
-2.3
—
-3.44422
-3.56399
-3.64838
-3.56618
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
4
0
6
1
Revenue
USD
Publication date not stated
1402300000
1455885510
1502000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1831097 CUSIP 00857U206 13F (30d) 4 filings 4 filers Visit website Investor relations